ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,924.93
-1.78%
S&P 500
5,222.64
0.16%
Dow Jones
39,527.20
0.35%
US Dollar vs Yen
155.838
0.29%
Brent Oil
83.755
-0.23%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Portage Biotech Inc (PRTG)

  7. Portage Biotech Inc (PRTG) ニュース

PRTG

Portage Biotech (PRTG)

Portage Biotech Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PRTG
日付受信時刻ニュースソース見出しコード企業名
2024/04/1221 : 01GlobeNewswire Inc.Portage Biotech Announces Plans to Expand its Evaluation of Strategic AlternativesNASDAQ:PRTGPortage Biotech Inc
2024/03/2621 : 01GlobeNewswire Inc.Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) sharesNASDAQ:PRTGPortage Biotech Inc
2024/03/0907 : 30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
2024/03/0907 : 04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2024/02/2907 : 19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
2024/02/2907 : 10GlobeNewswire Inc.Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business UpdateNASDAQ:PRTGPortage Biotech Inc
2024/02/1505 : 50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRTGPortage Biotech Inc
2024/01/1907 : 09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2024/01/0422 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2024/01/0422 : 00GlobeNewswire Inc.Portage Biotech Reports Business and Strategic UpdateNASDAQ:PRTGPortage Biotech Inc
2023/12/0206 : 05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRTGPortage Biotech Inc
2023/11/2906 : 03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
2023/11/2906 : 02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/11/2906 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/11/1420 : 00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
2023/11/1320 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/11/0814 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRTGPortage Biotech Inc
2023/11/0806 : 50Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
2023/11/0622 : 01GlobeNewswire Inc.Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual MeetingNASDAQ:PRTGPortage Biotech Inc
2023/11/0105 : 05Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:PRTGPortage Biotech Inc
2023/09/2921 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/09/0905 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/08/3021 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/08/3005 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/08/1505 : 52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/08/0106 : 12Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:PRTGPortage Biotech Inc
2023/06/2119 : 04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTGPortage Biotech Inc
2023/05/0121 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTGPortage Biotech Inc
2023/03/1419 : 02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTGPortage Biotech Inc
2023/01/0706 : 50Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTGPortage Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:PRTG

最近閲覧した銘柄

NYSE
VZ
Verizon Communications
NASDAQ
AAPL
Apple
CCOM
US500
US 500
USI
USTECH100
US Tech 100
USOTC
BASFY
BASF (QX)
COIN
SOLUSD
Solana
AMEX
XLE
Energy Select Sector SPDR
NYSE
MRK
Merck
NYSE
KO
Coca Cola
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
AXP
American Express
NASDAQ
TSLA
Tesla
NYSE
BAC
Bank of America
NYSE
MCD
McDonalds
NASDAQ
GOOGL
Alphabet
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有